Mylan Announces Generic Fenoglide Tablets


Mylan has announced receiving final approval from the FDA for its Abbreviated New Drug Application (ANDA) to produce a generic version of Santarus’s Fenoglide Tablets. Mylan’s generic version of the tablets will come in 40 mg and 120 mg dosages. According to IMS Health data, the tablets had sales of about $28.6 million for the 12 months prior to April of 2016.

Read the source article at Yahoo Finance

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>